A survey of minimally invasive surfactant therapy in Canada
Introduction: Minimally invasive surfactant therapy (MIST) can be used to treat neonatal respiratory distress syndrome in neonatal intensive care units (NICUs). Clinical and institutional variances in MIST utilization persist globally with little published research regarding MIST utilization in Cana...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Canadian Society of Respiratory Therapists
2022-07-01
|
| Series: | Canadian Journal of Respiratory Therapy |
| Subjects: | |
| Online Access: | https://www.cjrt.ca/wp-content/uploads/cjrt-2022-011.pdf |
| _version_ | 1811339493947473920 |
|---|---|
| author | Shaily Brahmbhatt Brooke Read Orlando Da Silva Soume Bhattacharya |
| author_facet | Shaily Brahmbhatt Brooke Read Orlando Da Silva Soume Bhattacharya |
| author_sort | Shaily Brahmbhatt |
| collection | DOAJ |
| description | Introduction: Minimally invasive surfactant therapy (MIST) can be used to treat neonatal respiratory distress syndrome in neonatal intensive care units (NICUs). Clinical and institutional variances in MIST utilization persist globally with little published research regarding MIST utilization in Canada.
Therefore, the objective of this study was to survey MIST utilization in NICUs in Canada.
Methods: An online survey was emailed to the 33 participating centres of Canadian Neonatal NetworkTM (CNN) Evidence-based Practice for Improving Quality (EPIQ) Lung Health Group (LHG). Site demographics and surfactant therapy procedural details were categorically collected. Free text and multiple-choice questions were utilized to capture perceived barriers and individual preferences for MIST use.
Results: Twenty-eight of 33 participating members of the CNN EPIQ-LHG completed the survey between April 2021 and October 2021 (85%); 17/28
(61%) respondents reported ongoing MIST utilization at their center. Most centers that used MIST techniques administered bovine lipid extract surfactant (68%), commonly using angiocatheters (47%) and purpose-built catheters (41%). MIST was widely used for patients at 26–33 weeks gestational age (88%). Nine centres had never used MIST (32%), and 3 indicated a plan to implement MIST within the next 2 years. Common barriers to MIST use included lack of consensus amongst clinicians (78%), lack of training (56%), and lack of experience with MIST (56%).
Conclusion: While MIST is being increasingly used in Canadian NICUs, universal use is yet to be seen. Clinician inexperience and lack of consensus, formal training, and local guidelines contribute to underutilization of MIST. Training workshops, country-wide data collection, and uniform operating protocols are needed to standardize practice. |
| first_indexed | 2024-04-13T18:27:29Z |
| format | Article |
| id | doaj.art-7ab989cd9ae54ca689e84c8d63f75154 |
| institution | Directory Open Access Journal |
| issn | 2368-6820 |
| language | English |
| last_indexed | 2024-04-13T18:27:29Z |
| publishDate | 2022-07-01 |
| publisher | Canadian Society of Respiratory Therapists |
| record_format | Article |
| series | Canadian Journal of Respiratory Therapy |
| spelling | doaj.art-7ab989cd9ae54ca689e84c8d63f751542022-12-22T02:35:12ZengCanadian Society of Respiratory TherapistsCanadian Journal of Respiratory Therapy2368-68202022-07-015812212610.29390/cjrt-2022-011A survey of minimally invasive surfactant therapy in CanadaShaily BrahmbhattBrooke ReadOrlando Da SilvaSoume BhattacharyaIntroduction: Minimally invasive surfactant therapy (MIST) can be used to treat neonatal respiratory distress syndrome in neonatal intensive care units (NICUs). Clinical and institutional variances in MIST utilization persist globally with little published research regarding MIST utilization in Canada. Therefore, the objective of this study was to survey MIST utilization in NICUs in Canada. Methods: An online survey was emailed to the 33 participating centres of Canadian Neonatal NetworkTM (CNN) Evidence-based Practice for Improving Quality (EPIQ) Lung Health Group (LHG). Site demographics and surfactant therapy procedural details were categorically collected. Free text and multiple-choice questions were utilized to capture perceived barriers and individual preferences for MIST use. Results: Twenty-eight of 33 participating members of the CNN EPIQ-LHG completed the survey between April 2021 and October 2021 (85%); 17/28 (61%) respondents reported ongoing MIST utilization at their center. Most centers that used MIST techniques administered bovine lipid extract surfactant (68%), commonly using angiocatheters (47%) and purpose-built catheters (41%). MIST was widely used for patients at 26–33 weeks gestational age (88%). Nine centres had never used MIST (32%), and 3 indicated a plan to implement MIST within the next 2 years. Common barriers to MIST use included lack of consensus amongst clinicians (78%), lack of training (56%), and lack of experience with MIST (56%). Conclusion: While MIST is being increasingly used in Canadian NICUs, universal use is yet to be seen. Clinician inexperience and lack of consensus, formal training, and local guidelines contribute to underutilization of MIST. Training workshops, country-wide data collection, and uniform operating protocols are needed to standardize practice.https://www.cjrt.ca/wp-content/uploads/cjrt-2022-011.pdfneonatesrespiratory distress syndromesurfactantsurvey |
| spellingShingle | Shaily Brahmbhatt Brooke Read Orlando Da Silva Soume Bhattacharya A survey of minimally invasive surfactant therapy in Canada Canadian Journal of Respiratory Therapy neonates respiratory distress syndrome surfactant survey |
| title | A survey of minimally invasive surfactant therapy in Canada |
| title_full | A survey of minimally invasive surfactant therapy in Canada |
| title_fullStr | A survey of minimally invasive surfactant therapy in Canada |
| title_full_unstemmed | A survey of minimally invasive surfactant therapy in Canada |
| title_short | A survey of minimally invasive surfactant therapy in Canada |
| title_sort | survey of minimally invasive surfactant therapy in canada |
| topic | neonates respiratory distress syndrome surfactant survey |
| url | https://www.cjrt.ca/wp-content/uploads/cjrt-2022-011.pdf |
| work_keys_str_mv | AT shailybrahmbhatt asurveyofminimallyinvasivesurfactanttherapyincanada AT brookeread asurveyofminimallyinvasivesurfactanttherapyincanada AT orlandodasilva asurveyofminimallyinvasivesurfactanttherapyincanada AT soumebhattacharya asurveyofminimallyinvasivesurfactanttherapyincanada AT shailybrahmbhatt surveyofminimallyinvasivesurfactanttherapyincanada AT brookeread surveyofminimallyinvasivesurfactanttherapyincanada AT orlandodasilva surveyofminimallyinvasivesurfactanttherapyincanada AT soumebhattacharya surveyofminimallyinvasivesurfactanttherapyincanada |